Bloomberg Law – Drug Price Negotiations Need ‘Nimble’ Approach, Official Says
The Medicare agency may eventually conduct rulemaking to standardize its new process for negotiating the prices of the highest spending drugs, a top official said Monday. Jonathan Blum, principal deputy administrator and chief operating officer at the Centers for Medicare & Medicaid Services, said the timeline Congress set in the Inflation Reduction Act (Public Law 117-169) to begin negotiating…